Latest Pharmaceutical Industry News from Global

News> Pharmaceutical

Sanofi’s Sarclisa Challenges Johnson & Johnson’s Darzalex: FDA Approves New First-Line Treatment, ...

Since its initial approval by the U.S. Food and Drug Administration (FDA) in 2020, Sarclisa, a drug made by Sanofi, has been specifically used to trea...
2024-09-23 15:51
BMS Layoffs: 79 Employees in New Jersey Face Unemployment, 2,200 Job Cuts Planned by 2025!

According to a Worker Adjustment and Retraining Notice (WARN), the renowned pharmaceutical company announced that it will lay off 79 employees in Lawr...
2024-09-23 15:50
Lonza Launches Innovaform Accelerator

Global CDMO Lonza recently opened a new facility at its Colmar, France site. The new Innovaform Accelerator will serve as a center of excellence to de...
2024-09-23 10:44
FDA Shocking Approval of Kisqali: 25% Increased Recurrence Risk for Early Breast Cancer Patients, Tr...

The benefit of invasive disease-free survival (iDFS) compared to receiving endocrine therapy (ET) alone was consistently observed in all patient subgr...
2024-09-20 17:33
FDA Grants Emergency Approval! Eli Lilly's IL-13 Inhibitor Ebglyss Poses New Crisis for Atopic Derma...

Eli Lilly recently announced that the U.S. Food and Drug Administration (FDA) has officially approved its IL-13 inhibitor Ebglyss (lebrikizumab).
2024-09-20 17:28
U.S. 301 Tariffs Hit Hard: Chinese Medical Device Industry Faces 50%-100% Tariff Increase, Company S...

The Office of the United States Trade Representative has officially announced the final implementation of the 301 tariffs on Chinese goods, which will...
2024-09-20 17:27
Povidone iodine solution first aid antiseptic: how does it work?

Povidone iodine solution first aid antiseptic is a type of iodine tincture, used for skin disinfection and sterilization before and after surgery, pre...
2024-09-20 17:25
GlaxoSmithKline Vaccine Combination Trial Fails: Joint Vaccination Shows Mediocre Results, 177,000 H...

The trial evaluated two of GSK's key vaccines, Shingrix and Arexvy, in adults over 50 years of age, successfully achieving the study's primary goal.
2024-09-19 16:22
$587 Million Valuation Doubts: BioAge Labs’ IPO Hides Crisis in Obesity Drug Market!

BioAge Labs, a biotechnology company focused on the field of obesity treatments, announced on Wednesday that it is seeking a valuation of up to $587 m...
2024-09-19 16:22
Gavi Invests $50 Million to Purchase 500,000 Vaccine Doses, Pandemic Death Toll Exceeds 700, Global ...

The Global Alliance for Vaccines and Immunization (Gavi) announced on Wednesday that it will procure 500,000 doses of a new smallpox vaccine produced ...
2024-09-19 16:21